Skip to main content
. 2018 May 17;8:7806. doi: 10.1038/s41598-018-26112-1

Table 4.

Functional annotations of SNPs in selected replicated 3-SNP haplotypes.

Chr 3-SNP haplotype SNP Chr position (hg19) Ontology Mapped gene DHS overlapa, # EIDs
(# PBC EIDs)
H3K4me1 overlapa, # EIDs
(# PBC EIDs)
H3K4me3 overlapa, # EIDs (# PBC EIDs) Bound proteinb:
Cell line (protein)
# Altered motifsc Significant eQTLsd:
Tissue (gene)
6 (rs3129881 = C) or ((rs375244 = A) and (rs3132947 = G)) rs3129881 32409484 intronic HLA-DRA 0 (0) 42 (20) 50 (17) GM12878 (OCT2, POL2, POL24H8, POU2F2); GM12891 (OCT2, POL2, POL24H8, POU2F2); GM12892 (POL2, POL24H8) 3 Whole Blood (C4A, C4B, HLA-DQA1, HLA-DQA2, HLA-DQB2, HLA-DRB5); Lymphoblastoid (HLA-DQA2, HLA-DRB5); Liver (HLA-DRB5)
rs375244 32191457 intronic NOTCH4 0 (0) 69 (15) 38 (3) NA 3 Whole Blood (GPSM3, NOTCH4)
rs3132947 32176782 intronic NOTCH4 0 (0) 2 (1) 4 (0) NA 3 Whole Blood (AGPAT1, C4A, C4B, CYP21A1P, HLA-DRA, PBX2, SKIV2L); Lymphoblastoid (C4A, HLA-DQA1, RNF5); Liver (AGPAT1, RNF5)
6 ((rs9268831 = T) or (rs9269190 = T)) or (rs9270652 = C) rs9268831 32427748 intergenic HLA-DRA (dist = 14922),
HLA-DRB5 (dist = 57406)
5 (1) 31 (19) 71 (16) GM18951 (POL2) 1 Whole Blood (HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DQB1-AS1, HLA-DQB2, HLA-DRB1, HLA-DRB6, HLA-DRB9);
Lymphoblastoid (HLA-DQA2, HLA-DQB2, HLA-DRB6, HLA-DRB9, NOTCH4); Liver (HLA-DQA2, HLA-DQB2)
rs9269190 32448500 intergenic HLA-DRA (dist = 35674),
HLA-DRB5 (dist = 36654)
2 (2) 4 (4) 2 (2) NA 2 Whole Blood (HLA-DRA)
rs9270652 32565905 intergenic HLA-DRB1 (dist = 8292),
HLA-DQA1 (dist = 39278)
1 (1) 1 (1) 2 (0) NA 0 NA
6 (rs9295704 = C) and ((rs2451752 = A) and (rs2575174 = C)) rs9295704e 26704816 intergenic ZNF322 (dist = 44836), GUSBP2 (dist = 134450) 0 (0) 13 (1) 8 (1) NA 4 Whole Blood (ABT1)
rs2451752e 26648013 intronic ZNF322 0 (0) 1 (1) 3 (1) NA 0 Whole Blood (BTN3A1, BTN3A2, HMGN4, ZNF322)
rs2575174e 25885552 intergenic SLC17A3 (dist = 11081),
SLC17A2 (dist = 27432)
0 (0) 5 (0) 0 (0) NA 2 Whole Blood (HIST1H1T, HIST1H4A)
7 ((rs12671658 = T) or (rs12702656 = A)) and (rs11768586 = G) rs12671658e 7842281 intronic UMAD1 1 (0) 6 (0) 2 (0) NA 7 NA
rs12702656e 7851742 intronic UMAD1 0 (0) 9 (3) 0 (0) NA 4 NA
rs11768586e 7849806 intronic UMAD1 1 (0) 6 (2) 1 (1) NA 0 NA
9 (rs4979484 = C) or ((rs13300483 = T) and (rs7028891 = G)) rs4979484e 117751450 intergenic TNFSF8 (dist = 58575),
TNC (dist = 30404)
22 (6) 33 (20) 11 (7) GM12878 (BATF, NFKB);
GM12891 (NFKB);
GM15510 (NFKB);
GM18951 (NFKB)
3 NA
rs13300483e 117643362 intergenic TNFSF15 (dist = 74954),
TNFSF8 (dist = 12261)
0 (0) 11 (6) 2 (0) NA 2 Whole Blood (TNFSF8)
rs7028891e 117645015 intergenic TNFSF15 (dist = 76607),
TNFSF8 (dist = 10608)
0 (0) 4 (3) 1 (1) NA 3 Whole Blood (TNFSF8)

Abbreviations: EID, epigenome identifier; dist, distance; #, number; DHS, DNase I hypersensitivity site; eQTL, expression quantitative trait loci.

aCounts of the number of consolidated cell types (EIDs) for which the SNP of interest overlaps the queried epigenomic assay peak (Roadmap Epigenomics Mapping Consortium processed data, Kundaje et al.)21. “PBC EID”: Separately considers peak overlap counts among the 29 blood/liver cell types available in Roadmap Epigenomics.

bBound protein: Regulatory protein-binding ChIP-seq peak overlaps for specified proteins are provided for blood- or liver-related cell lines only (HaploReg v4, Ward and Kellis)37.

cAltered motifs: The number of regulatory motifs predicted to be affected by the SNP based on position weight matrices (PWM) score changes (HaploReg v4, Ward and Kellis)37.

deQTLs: Reported significant eQTLs for whole blood, lymphoblastoid, and liver cell types only (GTEx Consortium20; HaploReg v4, Ward and Kellis)37.

eSignifies non-HLA SNPs.